SSSarah A. Shuda

Sarah A. Shuda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah A. Shuda has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Trends in Fentanyl Adulteration From Rapid Drug Analysis and Research (RaDAR) Drug Checking Samples, January 2024 to June 2026

    by Edward Sisco, Elise M. Pyfrom, Meghan G. Appley, Elizabeth L. Robinson, Katya A. Beltran, Sarah A. Shuda

    The illicitly manufactured fentanyl (IMF) market in the United States has grown increasingly adulterated, complicating public health and law enforcement responses. This study examines qualitative and quantitative fentanyl adulteration trends using data from the National Institute of Standards and Technology's (NIST) Rapid Drug Analysis and Research (RaDAR) program between January 2024 and June 2026. Analyzing 4563 qualitative and 1224 quantitative results from samples collected across 17 states, the research highlights significant geographic (East vs. West) and temporal shifts in the unregulated drug supply. Results indicate a sharp increase in sample complexity, with many samples containing over five compounds by late 2025. The data details the widespread emergence and subsequent regional shifts of α 2 ‐agonists (from xylazine to medetomidine), local anesthetics (lidocaine, tetracaine, and procaine), and the industrial chemical BTMPS. Quantitative findings reveal that IMF from the West consistently exhibited higher fentanyl purity (≈13% mass fraction) compared with the East (≈5% mass fraction). Furthermore, paired concentration analysis suggests that the presence of IMF in stimulants such as cocaine and methamphetamine likely stems from low‐level unintentional contamination rather than intentional mixing. Ultimately, this research underscores the volatility of the IMF supply and demonstrates the critical need for continuous, comprehensive drug checking networks to rapidly detect and respond to evolving adulteration trends.


  • Open Access

    Advancing Spectroscopy‐Based Drug Checking Training: A Proof‐of‐Concept Study for the Use of Concordance Analysis

    by Yarelix Estrada, Jeffery Sauer, Leonardo Dominguez, Mia Borrelli, Sarah A. Shuda, Amanda L. A. Mohr

    Introduction: Drug checking is a harm reduction strategy that provides information to people who use drugs. Currently, there is a lack of standardised, replicable methods to assess drug checking technicians' use of spectroscopy‐based technologies. Methods: This paper introduces concordance analysis as a method to assess drug checking technician accuracy using Fourier transform infrared (FTIR) spectroscopy. Drug checking technicians provided point‐of‐care drug checking services, including FTIR, at participating syringe service programs in New York City beginning in November 2021. Drug checking technicians analysed drug samples and identified compounds based on spectra, test strips and contextual information provided by the individuals submitting samples. The drug checking technician results were compared to results obtained from a secondary laboratory testing partner. Technicians aimed to achieve a 90% concordance rate for sample composition determinations in the field as compared to secondary laboratory testing results. Results: Two drug checking technicians encountered a total of N = 362 samples over the course of their training periods. Concordance analysis showed that both technicians completed their training period above the target accuracy level (Technician A 137/151 or 90.7% concordant, Technician B 196/211 or 92.9% concordant). The training periods for Technician A and Technician B were 33 and 38 weeks, respectively. Both technicians demonstrated improvement over time. Discussion and Conclusions: These results indicate that drug checking technicians with no formal background in analytical chemistry are able to accurately identify compounds present in real‐world drug samples using an FTIR, thus supporting the merit of these techniques in drug checking programs.


  • Open Access

    Determination of the Enantiomeric Makeup of Ketamine in Street Drug Samples

    by Sarah A. Shuda, Edward Sisco

    Ketamine is an anesthetic drug used recreationally for its psychoactive effects. Recently, the use of ketamine has increased. Ketamine is a chiral compound with two enantiomers, S-ketamine (esketamine) and R-ketamine (arketamine). Though the S- enantiomer is more potent, pharmaceutical ketamine is most often racemic. Asymmetric synthesis or optical resolution can be performed to increase the percentage of S-ketamine in samples, thereby increasing the potency. To investigate the form of ketamine present in the illicit drug supply, chiral liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to analyze 139 drug paraphernalia residue or drug product samples submitted from August 2025 to February 2026. All samples analyzed were found to contain racemic ketamine.

  • Effect of liner properties on the analysis of lysergic acid diethylamide ( LSD ) analogs

    by Sarah A. Shuda

    Lysergic acid diethylamide (LSD) and analogs are psychedelic drugs commonly submitted to forensic chemistry laboratories. These drugs are often present on items of evidence at low concentrations, requiring sensitive analyses to positively identify their presence. The injection port of a gas chromatograph (GC) plays an important role in vaporizing and transferring substances to the column for separation and subsequent detection. The consumables in the inlet, specifically the liner, can influence the abundance and chromatography of compounds being analyzed. Twelve liners with varying geometries, packing materials, and deactivation chemistries were assessed by analyzing a mixture of eight LSD‐related compounds and comparing the average peak areas. Liners containing packing materials yielded significantly higher peak areas as compared to those without. The geometry of the liner played a smaller role and affected results only with one deactivation when glass wool was not present. Base deactivation improved peak area when compared to standard and Topaz deactivation in straight liners with packing. Authentic samples were analyzed on liners with varying deactivation chemistries to determine the effect over a run of seven replicates of 10 street samples (70 sample injections). Peak area with base‐deactivated liners and liners with standard deactivation remained consistent over time, whereas the liner with Topaz deactivation decreased in peak area 52–68% after the initial injection and demonstrated a decrease in peak area of 30–54% from the first injection to the final injection.


  • Enantiomeric Determination of Medetomidine in Street Drug Samples (August 2024—February 2025) and Implications for Immunoassay Test Strip Analysis

    by Edward Sisco, Mónica Ventura, Sarah A. Shuda

    Over the last several years, there has been an influx of α 2 ‐agonists into the street drug supply, beginning with the proliferation of xylazine, a potent veterinary sedative. Since 2023, another sedative, medetomidine, has been widely detected. Medetomidine, broadly, encompasses two enantiomers—dexmedetomidine and levomedetomidine—with the dex enantiomer being pharmacologically active and present in human‐use pharmaceuticals. In this work, we investigate street drug samples containing medetomidine to better understand the enantiomeric makeup in the illicit supply. Liquid chromatography tandem mass spectrometry (LC–MS/MS) was used to analyze 100 drug product or paraphernalia residue samples. All samples were found to contain a racemic mixture of medetomidine. A subset of samples was analyzed by medetomidine immunoassay test strips, where racemic mixtures were not found to negatively affect results. All samples were also qualitatively analyzed using direct analysis in real time mass spectrometry (DART‐MS) to identify commonly co‐occurring compounds, which included fentanyl, xylazine, and local anesthetics. Parabens, preservatives found in licit injectable preparations of the drug, were not detected. This work provides a snapshot into the medetomidine makeup of the street drug supply, which needs to be continually monitored given the differences in pharmacology between the two enantiomers.


  • Open Access

    Isomeric Determination of Medetomidine in Street Drug Samples (August 2024 – February 2025) and Implications for Immunoassay Test Strip Analysis

    by Edward Sisco, Mónica Ventura, Sarah Shuda

    Over the last several years there has been an influx of α2-agonists into the street drug supply. This began with the proliferation of xylazine, a potent veterinary sedative. Since 2023, another sedative, medetomidine, has been widely detected. Medetomidine, broadly, encompasses two optical isomers – dexmedetomidine and levomedetomidine – with the dex- isomer being pharmacologically active and used in licit human formulations. In this work, we investigate street drug samples containing medetomidine to better understand their isomeric makeup in the illicit supply. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to analyze 100 drug product or paraphernalia residue samples. All samples were found to contain a racemic mixture of medetomidine. A subset of samples were analyzed by medetomidine immunoassay test strips, where racemic mixtures were not found to negatively affect results. All samples were also qualitatively analyzed using direct analysis in real time mass spectrometry (DART-MS) to identify commonly co-occurring compounds, which included fentanyl, xylazine, and local anesthetics. Parabens, preservatives found in licit injectable preparations of the drug, were not detected. This work provides a snapshot into the medetomidine makeup of street drug supply, which needs to be continually monitored given the differences in pharmacology between the two optical isomers.


  • Open Access

    Effect of Liner Properties on the Analysis of Lysergic Acid Diethylamide (LSD) Analogs

    by Sarah Shuda

    Lysergic acid diethylamide (LSD) and analogs are psychedelic drugs commonly submitted to forensic chemistry laboratories. These drugs are often present on items of evidence at low concentrations, requiring sensitive analyses to positively identify their presence. The injection port of a gas chromatograph (GC) plays an important role in vaporizing and transferring substances to the column for separation and subsequent detection. The consumables in the inlet, specifically the liner, can influence the abundance and chromatography of compounds being analyzed. Twelve liners with varying geometries, packing material, and deactivation chemistries were assessed by analyzing a mixture of eight LSD related compounds and comparing the average peak areas. Liners containing packing material led to significantly higher responses than those without. Liner geometry played a smaller role and affected results only with one deactivation when glass wool was not present. Base deactivation improved peak area when compared to standard and Topaz deactivation in straight liners with packing. Authentic samples were analyzed on liners with varying deactivation chemistries to determine the effect over a run of seventy samples. Response with base deactivated liners and liners with standard deactivation remained consistent over time, whereas the liner with Topaz deactivation decreased in response 52 % to 68 % after the initial injection and demonstrated a decrease in response of 30 % to 54 % from the first injection to the final injection.